Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RHOPRESSA® safely and effectively. See full prescribing information for RHOPRESSA®. RHOPRESSA® (netarsudil ophthalmic solution) 0.02%, for topical ophthalmic use Initial U.S. Approval: 2017
Medication labelWhy this: Advisory · dailymed-prescription
RHOPRESSA is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
- generic_name
- netarsudil
- product_names
- netarsudil
- ndc
- 70727-497, 70727-497-25, 70727-497-99
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en